Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450242 · ClinicalTrials.gov registry record · Phase 2
5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT00450242 is a Phase 2 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 14 participants.
The verdict
NCT00450242, a Phase 2 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
* Study Hypothesis: Use of 5% topical lidocaine ointment will result in improved ability to have sexual intercourse and decreased pain scores in women with vestibulitis when compared to placebo. * This is a study to assess if topical lidocaine will improve symptoms in women with vulvar vestibulitis. It compares use of nightly 5% topical lidocaine ointment to placebo ointment. The duration of the study is 8 weeks. 28 women will be in each arm for a total of 56 women in the study.
Interventions
- DRUG Placebo cream
- DRUG 5% topical lidocaine ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450242
The ClinicalTrials.gov registry entry for NCT00450242 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo cream is the first listed.
NCT00450242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450242 about?
NCT00450242 is a clinical study titled "5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis". * Study Hypothesis: Use of 5% topical lidocaine ointment will result in improved ability to have sexual intercourse and decreased pain scores in women with vestibulitis when compared to placebo. * This is a study to assess if topical lidocaine will improve symptoms in women with vulvar vestibulitis....
What is the current status of trial NCT00450242?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2006-12. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00450242?
The interventions under investigation include: Placebo cream (DRUG), 5% topical lidocaine ointment (DRUG).
Who is sponsoring clinical trial NCT00450242?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.